Dermatology · Chestnut Hill, MA
NPI
1154383610
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1244 Boylston St, Suite 302
Chestnut Hill, MA, 02467
Phone (617) 731-1600
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
21,417 services
Medicare patients, 2024
1,238
Average age 75
Drug cost, 2024
$4.1M
1,812 prescriptions
Company payments, 2025
$168K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey M Sobell was code J3245 (injection, tildrakizumab, 1 mg), 11,300 times for 30 patients. In total Jeffrey M Sobell billed 21,417 services in 51 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3245 Injection, tildrakizumab, 1 mg | Office | 11,300 | 30 | $107.45 | $1.2M |
| 17003 Destruction Skin Lesion | Office | 2,568 | 394 | $5.69 | $15K |
| 99213 Office E&M - Established | Office | 1,165 | 819 | $68.25 | $80K |
| 17000 Destruction Skin Lesion | Office | 745 | 520 | $46.19 | $34K |
| 17110 Destruction Skin Lesion | Office | 371 | 303 | $92.38 | $34K |
| 99214 Office E&M - Established | Office | 312 | 210 | $97.57 | $30K |
| 11102 Skin Biopsy | Office | 243 | 209 | $77.85 | $19K |
| 17003 Destruction Skin Lesion | Facility | 140 | 33 | $1.71 | $239 |
| 99212 Office E&M - Established | Office | 131 | 111 | $43.64 | $5,717 |
| 96372 Injection Administration | Office | 119 | 34 | $11.27 | $1,341 |
| 99213 Office E&M - Established | Facility | 78 | 63 | $51.83 | $4,042 |
| 11103 Skin Biopsy | Office | 54 | 36 | $45.24 | $2,443 |
| 17000 Destruction Skin Lesion | Facility | 48 | 41 | $42.20 | $2,025 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 47 | 25 | $0.74 | $34.68 |
| 99203 Office E&M - New | Office | 44 | 44 | $78.09 | $3,436 |
By year: 2022 $1.1M for 17,631 services; 2023 $1.4M for 20,531 services; 2024 $1.6M for 21,417 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey M Sobell prescribed most often to Medicare patients was Clobetasol Propionate, with 150 prescriptions and refills. In total Jeffrey M Sobell wrote 1,812 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 150 | 165 | 87 | $10K |
| Ketoconazole Generic | 97 | 97 | 61 | $1,370 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 95 | 109 | 55 | $6,192 |
| Methotrexate Methotrexate Sodium | 91 | 188 | 21 | $2,445 |
| Triamcinolone Acetonide Generic | 81 | 88 | 63 | $790 |
| Taltz Autoinjector Ixekizumab | 77 | 84 | Under 11 | $574K |
| Dupixent Pen Dupilumab | 57 | 67 | Under 11 | $275K |
| Clindamycin Phosphate Generic | 52 | 53 | 23 | $1,862 |
| Metronidazole Generic | 51 | 57 | 26 | $1,978 |
| Hydrocortisone Generic | 49 | 49 | 29 | $208 |
| Doxycycline Hyclate Generic | 49 | 111 | 21 | $2,130 |
| Humira(Cf) Pen Adalimumab | 48 | 48 | Under 11 | $327K |
| Minoxidil Generic | 44 | 85 | Under 11 | $233 |
| Tacrolimus Generic | 44 | 48 | 27 | $5,556 |
| Fluocinolone Acetonide Generic | 42 | 44 | 27 | $1,847 |
Brand drugs: 543 claims; generic drugs: 1,269 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey M Sobell $168K ($168K in general payments such as food, travel and fees) from 23 companies. The largest payer was Janssen Biotech, Inc. with $42K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 122 | $42K |
| UCB, Inc. UCB.BR | 23 | $27K |
| Arcutis Biotherapeutics, Inc. ARQT | 19 | $22K |
| Abbvie Inc. ABBV | 29 | $21K |
| Lilly USA, LLC LLY | 18 | $20K |
| Organon LLC OGN | 20 | $16K |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $6,538 |
| Genzyme Corporation SNY | 3 | $6,006 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 11 | $5,941 |
| Amgen Inc. AMGN | 5 | $1,741 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.